The estimated Net Worth of Calvin H Knowlton is at least $61.9 Million dollars as of 23 December 2021. Calvin Knowlton owns over 20,000 units of Tabula Rasa HealthCare Inc stock worth over $3,888,644 and over the last 8 years he sold TRHC stock worth over $52,906,104. In addition, he makes $5,135,730 as Chairman of the Board, Chief Executive Officer, and Co-Founder at Tabula Rasa HealthCare Inc.
Calvin has made over 91 trades of the Tabula Rasa HealthCare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of TRHC stock worth $296,400 on 23 December 2021.
The largest trade he's ever made was exercising 688,288 units of Tabula Rasa HealthCare Inc stock on 26 January 2017 worth over $2,643,026. On average, Calvin trades about 26,309 units every 18 days since 2016. As of 23 December 2021 he still owns at least 370,347 units of Tabula Rasa HealthCare Inc stock.
You can see the complete history of Calvin Knowlton stock trades at the bottom of the page.
Dr. Calvin H. Knowlton Ph.D. serves as Chairman of the Board, Chief Executive Officer, Co-Founder of the Company. He has served as Chairman and Chief Executive Officer of CareKinesis since May 2009. Dr. Calvin Knowlton founded excelleRx Inc., a national hospice medication management pharmacy serving the elderly, where he acted as President and Chief Executive Officer from April 1995 through July 2007. Dr. Knowlton currently serves on the Board of The Evergreens, an Acts Community, the Board of the Cooper Medical School of Rowan University, and the Session of the First Presbyterian Church of Moorestown. Dr. Calvin Knowlton previously served on the Board of Coriell Institute for Medical Research, the Board of St. Christopher’s Hospital for Children in Philadelphia and the Board of Settlement Music School in Philadelphia. Dr. Knowlton has also served on the national Pharmacogenomics Advisory Group from 2011 to 2012, as President of the American Pharmacists Association from 1994 to 1996, and President of the American Pharmacist Association Foundation from 2008 to 2009. Dr. Knowlton received the Ernst & Young Entrepreneur of the Year technology award for the Greater Philadelphia Region in 2003 and in 2013. Dr. Knowlton was also awarded the highest national honor in pharmacy, the Remington Honor Medal, in 2015. Dr. Calvin Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary and his Ph.D. in Pharmacoeconomics from the University of Maryland. Dr. Calvin Knowlton is married to Dr. Orsula Knowlton.
As the Chairman of the Board, Chief Executive Officer, and Co-Founder of Tabula Rasa HealthCare Inc, the total compensation of Calvin Knowlton at Tabula Rasa HealthCare Inc is $5,135,730. There are no executives at Tabula Rasa HealthCare Inc getting paid more.
Calvin Knowlton is 70, he's been the Chairman of the Board, Chief Executive Officer, and Co-Founder of Tabula Rasa HealthCare Inc since 2014. There are 3 older and 14 younger executives at Tabula Rasa HealthCare Inc. The oldest executive at Tabula Rasa HealthCare Inc is A. Gordon Tunstall, 76, who is the Lead Independent Director.
Calvin's mailing address filed with the SEC is 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN, NJ, 08057.
Over the last 8 years, insiders at Tabula Rasa HealthCare Inc have traded over $245,667,405 worth of Tabula Rasa HealthCare Inc stock and bought 1,486,398 units worth $7,620,320 . The most active insiders traders include Calvin H Knowlton, Orsula V Knowlton, and Capital Management, L.P.Ic .... On average, Tabula Rasa HealthCare Inc executives and independent directors trade stock every 8 days with the average trade being worth of $441,116. The most recent stock trade was executed by Michael Greenhalgh on 28 June 2023, trading 25,000 units of TRHC stock currently worth $77,750.
the tabula rasa healthcare family of companies provide new beginnings for our clients, through innovative service models and fresh approaches to healthcare technology. our leaders understand that to maximize patient experiences and outcomes, they must help providers to balance efficiency and scalability with safety and individualization of care.
Tabula Rasa HealthCare Inc executives and other stock owners filed with the SEC include: